CAMP Q2 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M+7.7% YoY

Gross Profit

$38M40.1% margin

Operating Income

-$574,000-0.6% margin

Net Income

$9M9.0% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$493M

Total Liabilities

$291M

Stockholders' Equity

$202M

Cash & Equivalents

$170M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$88M	+7.7%
Gross Profit	$38M	$37M	+1.7%
Operating Income	-$574,000	-$1M	+56.8%
Net Income	$9M	-$3M	+420.7%

Revenue Segments

Telematics Systems

$76M80%

Software And Subscription Services

$19M20%

Geographic Segments

UNITED STATES

$70M74%

Europe Middle East And Africa

$13M14%

South America

$4M4%

Asia Pacific

$4M4%

All Other

$2M2%

CANADA

$1M1%